Early childhood education in Hong Kong has become big business, attracting more entrepreneurs and increased investment in the industry. [Provided to China Daily] Trade wars and rising interest rates have taken away much of the shine of stocks and properties. If you, like many other Hong Kong investors, are thinking of selling out while the times are still good, you may want to know there's a new game in town that has whetted the interest not only of local entrepreneurs but also millionaire investors on the Chinese mainland. You don't have to be an educator or a social analyst to notice the obsession of many parents in Hong Kong and on the mainland with giving their toddlers a head start. Many children as young as two years of age are drilled by their eager parents to prepare for examinations to qualify for admission to some of the most prestigious nurseries and kindergartens. The strong demand has turned pre-school education into a big business, sucking up hundreds of millions of new investment funds from entrepreneurs, as well as investors who have grown wary of the stock and property markets. As a result, some of the better known play schools and kindergartens have become prized take-over targets. Even the special schools, especially those that teach local pre-school children usage of the English language, are in demand. Investors in pre-school education reportedly include young entrepreneurs who are interested in running the schools. There's no shortage of passive investors who are interested only in the earnings potential of these facilities. A mainland investor has reportedly bought a well-known kindergarten in Hong Kong because he can't get over the fact that he couldn't find a good kindergarten for his children when they were young. In Hong Kong, all kindergartens are privately owned and operated although they have to register with the government and subject to regular inspections by the Education Bureau. Since the introduction of the Quality Assurance Framework in 2012, the government regularly publishes a set of Performance Indicators for public reference. But, it's word of mouth that determines the popularity of a kindergarten. The more famous one can charge a fee of up to several thousand dollars per student. That's good business. band wristbandscustom sweatbands no minimumflash drive wristbandjordan wristband rubberrubber bracelets custom cheapcustom rubber bands
BEIJING -- China is working to reduce the prices of cancer drugs and the financial burden on patients, according to health officials Saturday. Prices of cancer drugs will be reduced through centralized negotiations and procurement, Zeng Yixin, vice director of the National Health Commission, said at a press conference. According to Chen Jinfu, head of the medical insurance department of the Ministry of Human Resources and Social Security, last year the government reached agreements with pharmaceutical enterprises on the prices of 36 cancer medicines on the medical insurance list. Prices of these drugs have been marked down by 44 percent on average, Chen said. Stressing a patient-centered approach in negotiations, the official also noted that market competition is also needed. The government will work to include more antineoplastic drugs into the country's catalogue of medical insurance reimbursement, which already incorporates most of the relevant drugs. Moreover, efforts have been made in accelerating the review and approval procedures for new medicines, reducing circulation costs and improving diagnosis to reduce the burden on patients and their families, Zeng said. The average approval time for imported drugs has been significantly shortened, and the customs clearance procedures streamlined, said Li Jinju, an official with China Food and Drug Administration. The Ministry of Finance announced Monday that China will exempt 28 drugs from import tariffs, including all cancer drugs from May 1, as part of wider opening of the market. Admitting that the tariff cut may challenge China's domestic pharmaceutical industry, Liu Dengfeng of the health commission expressed confidence in tackling it. China's medical research and development has progressed in recent years with the talent pool getting stronger and innovation booming, he said.
